커밀-치-메가클론

CUMYL-CH-MEGACLONE
커밀-치-메가클론
CUMYL-CH-MEGACLONE structure.png
법적현황
법적현황
식별자
  • 2,5-디히드로-2-(1-메틸-1-페닐틸틸)-5-(사이클로헥실메틸)-1H피리도[4,3-b]인돌-1-1
화학 및 물리적 데이터
공식C27H30N2O
어금질량398.54 g·190−1
3D 모델(JSmol)
  • CC(C)(c1ccc1)N5C=Ccc4n(CC2CCCC2)c3cc3cc4C5=o

CUMIL-CH-MEGACLONE(CUMIL-CHMGACLONE, SGT-270)은 감마-카볼린 기반 합성 카나비노이드 수용체 작용제로, 2018년 12월 헝가리에서 처음 식별되었다.[1][2][3]

참고 항목

참조

  1. ^ Alam RM, Keating JJ (March 2020). "Adding more "spice" to the pot: A review of the chemistry and pharmacology of newly emerging heterocyclic synthetic cannabinoid receptor agonists". Drug Testing and Analysis. 12 (3): 297–315. doi:10.1002/dta.2752. PMID 31854124. S2CID 209417068.
  2. ^ Haschimi B, Giorgetti A, Mogler L, Nagy TZ, Kramer S, Halter S, et al. (June 2020). "The Novel Psychoactive Substance Cumyl-CH-MEGACLONE: Human Phase-I Metabolism, Basic Pharmacological Characterization, and Comparison to Other Synthetic Cannabinoid Receptor Agonists with a γ-Carboline-1-one Core". Journal of Analytical Toxicology. 45 (3): 277–290. doi:10.1093/jat/bkaa065. PMID 32514544.
  3. ^ Institóris L, Kovács K, Sija É, Berkecz R, Körmöczi T, Németh I, Elek I, Bakos Á, Urbán I, Pap C, Kereszty É (June 2021). "Clinical symptoms and blood concentration of new psychoactive substances (NPS) in intoxicated and hospitalized patients in the Budapest region of Hungary (2018-19)". Clinical Toxicology. Philadelphia, Pa.: 1–7. doi:10.1080/15563650.2021.1928162. PMID 34080493. S2CID 235321374.
Stub icon

이 카나비노이드 관련 기사는 단조롭다. 위키피디아를 확장하여 도울 수 있다.